Katy McLaughlin on Muck Rack

Katy McLaughlin

Los Angeles
As seen in: McKinsey Quarterly, The Wall Street Journal, MarketWatch, The Toronto Star, Realtor.com, Cell Press, Mansion Global, RealClear Markets, The Cureus Journal of Medical Science, BioProcess International Magazine, Pharmaceutical Online and
I'm a senior editor at McKinsey & Company
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Katy

Contact Katy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Downstream AAV Production: Tools For Efficient And Reliable Gene Therapy Manufacturing

|
By Paul Cashen, Katy McLaughlin, Benjamin Graf
| Cell & Gene
By Paul Cashen, Katy McLaughlin, and Benjamin Graf, Sartorius Efficient downstream processing of adeno-associated virus (AAV) vectors is critical to advancing gene therapy from research to clinical and commercial manufacturing. This white paper explores the unique challenges of AAV purification—including low yields, impurity removal, and serotype-specific process variability—and offers practical strategies to overcome them.
Open in Who Shared Issue with article?

Downstream AAV Production: Tools For Efficient And Reliable Gene Therapy Manufacturing

|
By Paul Cashen, Katy McLaughlin, Benjamin Graf
| Bioprocess Online
By Paul Cashen, Katy McLaughlin, and Benjamin Graf, Sartorius Efficient downstream processing of adeno-associated virus (AAV) vectors is critical to advancing gene therapy from research to clinical and commercial manufacturing. This white paper explores the unique challenges of AAV purification—including low yields, impurity removal, and serotype-specific process variability—and offers practical strategies to overcome them.
Open in Who Shared Issue with article?

Downstream AAV Production: Tools For Efficient And Reliable Gene Therapy Manufacturing

|
By Paul Cashen, Katy McLaughlin, Benjamin Graf
| ecmconnection.com
By Paul Cashen, Katy McLaughlin, and Benjamin Graf, Sartorius Efficient downstream processing of adeno-associated virus (AAV) vectors is critical to advancing gene therapy from research to clinical and commercial manufacturing. This white paper explores the unique challenges of AAV purification—including low yields, impurity removal, and serotype-specific process variability—and offers practical strategies to overcome them.
Open in Who Shared Issue with article?
See all 375 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Katy

Contact Katy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified